BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22748747)

  • 1. Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD.
    Canto ND; Ribeiro JP; Neder JA; Chiappa GR
    Respir Med; 2012 Oct; 106(10):1404-12. PubMed ID: 22748747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
    Berton DC; Reis M; Siqueira AC; Barroco AC; Takara LS; Bravo DM; Andreoni S; Neder JA
    Respir Med; 2010 Sep; 104(9):1288-96. PubMed ID: 20580216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
    Tashkin DP; Hanania NA; McGinty J; Denis-Mize K; Chaudry I
    Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
    Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
    Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
    van Noord JA; Aumann JL; Janssens E; Smeets JJ; Verhaert J; Disse B; Mueller A; Cornelissen PJ
    Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender.
    Tashkin DP; Varghese ST
    Pulm Pharmacol Ther; 2011 Feb; 24(1):147-52. PubMed ID: 20659577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
    Travers J; Laveneziana P; Webb KA; Kesten S; O'Donnell DE
    Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?
    Akkoca Yildiz O; Onen ZP; Demir G; Eriş Gülbay B; Saryal S; Karabiyikoğlu G
    Tuberk Toraks; 2006; 54(2):105-13. PubMed ID: 16924565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
    Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG
    Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD.
    Terzano C; Petroianni A; Conti V; Ceccarelli D; Graziani E; Sanduzzi A; D'Avelli S
    Respir Med; 2008 Dec; 102(12):1701-7. PubMed ID: 18760583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
    Szmidt M
    Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized crossover study.
    Abe T; Setoguchi Y; Kono Y; Togashi Y; Sugiyama S; Tanakadate M; Soeda S; Nakai M; Sugiyama N; Fujiwara A; Yamaguchi K; Yamaguchi A; Kurita N
    Pulm Pharmacol Ther; 2011 Oct; 24(5):617-24. PubMed ID: 21689775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
    Vogelmeier C; Kardos P; Harari S; Gans SJ; Stenglein S; Thirlwell J
    Respir Med; 2008 Nov; 102(11):1511-20. PubMed ID: 18804362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.
    Tashkin DP; Pearle J; Iezzoni D; Varghese ST
    COPD; 2009 Feb; 6(1):17-25. PubMed ID: 19229704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.
    Tashkin DP; Donohue JF; Mahler DA; Huang H; Goodwin E; Schaefer K; Hanrahan JP; Andrews WT
    Respir Med; 2009 Apr; 103(4):516-24. PubMed ID: 19208459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of formoterol on exercise tolerance in severely disabled patients with COPD.
    Neder JA; Fuld JP; Overend T; Thirlwell J; Carter R; Stevenson R; Ward SA
    Respir Med; 2007 Oct; 101(10):2056-64. PubMed ID: 17658249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study.
    Di Marco F; Verga M; Santus P; Morelli N; Cazzola M; Centanni S
    Respir Med; 2006 Nov; 100(11):1925-32. PubMed ID: 16626956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study.
    Dal Negro RW; Turati C; Micheletto C; Menegoni F
    Ther Adv Respir Dis; 2012 Apr; 6(2):97-105. PubMed ID: 22250038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.